Mariah N Mason
Overview
Explore the profile of Mariah N Mason including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
98
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Prado R, Francis S, Mason M, Wing G, Gamble R, Dellavalle R
Dermatol Surg
. 2011 Sep;
37(11):1566-78.
PMID: 21895847
No abstract available.
2.
Mason M, Mahoney M
J Biomed Mater Res A
. 2010 Jul;
95(1):283-93.
PMID: 20607870
Developing a mechanism to vascularize tissue-engineered constructs is imperative for transplant function and integration, particularly when delivering hypoxia-sensitive tissues, such as pancreatic islets. Previous efforts have focused on bulk modifications...
3.
Mason M, Mahoney M
Tissue Eng Part A
. 2010 Mar;
16(8):2593-603.
PMID: 20236034
We assessed the ability of a gamma-secretase inhibitor to promote the in vitro differentiation of induced embryonic pancreatic precursor cell aggregates into functional islet-like clusters when encapsulated within a three-dimensional...
4.
Mason M, Arnold C, Mahoney M
Tissue Eng Part A
. 2009 Jun;
15(12):3799-808.
PMID: 19537960
Development of an alternative source of functional, transplantable beta-cells to replace or supplement cadaveric tissue is critical to the future success of islet cell transplantation therapy. Embryonic pancreatic precursor cells...
5.
Mason M, Mahoney M
Tissue Eng Part A
. 2008 Dec;
15(6):1343-52.
PMID: 19072086
Continuing advances in islet cell transplantation have been promising; however, several limitations, including severe shortage of transplantable islets, hinder the widespread use of this therapy. Pancreatic precursor cells are one...
6.
Burdick J, Mason M, Hinman A, Thorne K, Anseth K
J Control Release
. 2002 Sep;
83(1):53-63.
PMID: 12220838
Degradable poly(ethylene glycol) (PEG) hydrogels with varying mass loss profiles were investigated to assess their applicability as delivery vehicles for osteoinductive growth factors in bone tissue engineering. Protein release is...